Effect of transcatheter prostatic arterial embolization for treatment of prostatic hyperplasia
10.13929/j.1672-8475.201901005
- Author:
Cunwei CUI
1
Author Information
1. Department of Medical Imaging,Shanxi Medical University
- Publication Type:Journal Article
- Keywords:
Embolization, therapeutic;
Prostatic hyperplasia;
Treatment outcome
- From:
Chinese Journal of Interventional Imaging and Therapy
2019;16(5):259-263
- CountryChina
- Language:Chinese
-
Abstract:
Objective: To assess the safety and efficacy of prostatic arterial embolization (PAE) for prostatic hyperplasia patients intolerant or reluctant to surgery and with poor effects of drug therapy. Methods: A total of 15 patients with prostatic hyperplasia and moderate-severe lower urinary tract symptoms (LUTS) who were uncontrollable of drug therapy were treated with PAE. The postoperative complications were observed. The international prostate symptom score (IPSS) and quality of life (Qol) were obtained at 1, 3, 6 and 12 months during following-up after surgery. Statistical analysis was used to compare IPSS and Qol before and after treatment. Results: No serious complication occurred after PAE, while mild abdominal pain or burning sensation of urinary tract (3/15, 20.00%), ecchymosis at the puncture site (1/15, 6.67%) and different degrees of fever(4/15, 26.67%)were observed. There were significant differences of IPSS and Qol among different time points before and after treatment (F=8.90, 15.97, both P<0.01). Pairwise comparison showed IPSS and Qol at 1, 3, 6 and 12 months after treatment were significantly lower than those before treatment (all P<0.01). Conclusion: PAE is safe and effective for treatment of prostatic hyperplasia patients intolerant of or reluctant to surgery and with poor effects of drug therapy.
